Cronos Group Inc
NASDAQ:CRON
Cronos Group Inc
NASDAQ:CRON
Price:
2.48
USD
1.64%
Market Cap:
$947.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cronos Group Inc
NASDAQ:CRON
|
CA |
|
Grupo Aval Acciones y Valores SA
NYSE:AVAL
|
CO |
|
Industria de Diseno Textil SA
OTC:IDEXY
|
ES |
|
E
|
ESAB Corp
NYSE:ESAB
|
US |
Multiples-Based Value
The Multiples-Based Value of one
CRON
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 2.48 USD,
Cronos Group Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRON Multiples-Based Value
LOCKED
Multiples Across Competitors
CRON Competitors Multiples
Cronos Group Inc Competitors
Cronos Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Cronos Group Inc
NASDAQ:CRON
|
1.3B USD | 6.5 | -100.8 | -299.9 | -8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 13.3 | 41.8 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.4 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.1 | 7.5 | 8.8 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.2 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
